BIT 0.00% 2.0¢ biotron limited

BIT036- a likely candidate for curing COVID-19, page-912

  1. 2,856 Posts.
    lightbulb Created with Sketch. 2431
    Biotron's first published research paper into SARS has been cited 137 times according to PubMed, of which the last 47 times have been since the beginning of the pandemic, meaning that their research into the E protein is very topical among researchers presently.

    Here is a link to their first paper; SARS coronavirus E protein forms cation-selective ion channels

    You can follow the citations from this page and see all the recent papers.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.